14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ABEO stock ended at $4.56. This is 4.60% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 11.56% from a day low at $4.54 to a day high of $5.07.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Oct 25, 2013 $0.340 $0.340 $0.320 $0.330 5 000
Oct 24, 2013 $0.330 $0.340 $0.320 $0.340 55 000
Oct 23, 2013 $0.350 $0.350 $0.330 $0.340 50 000
Oct 22, 2013 $0.340 $0.380 $0.330 $0.350 80 000
Oct 21, 2013 $0.340 $0.370 $0.340 $0.340 15 000
Oct 18, 2013 $0.380 $0.380 $0.340 $0.350 45 000
Oct 17, 2013 $0.390 $0.390 $0.340 $0.380 50 000
Oct 16, 2013 $0.350 $0.390 $0.350 $0.390 35 000
Oct 15, 2013 $0.390 $0.390 $0.380 $0.380 10 000
Oct 14, 2013 $0.390 $0.420 $0.380 $0.390 40 000
Oct 11, 2013 $0.340 $0.400 $0.340 $0.390 85 000
Oct 10, 2013 $0.360 $0.400 $0.340 $0.390 30 000
Oct 09, 2013 $0.360 $0.390 $0.360 $0.360 0
Oct 08, 2013 $0.380 $0.400 $0.350 $0.390 5 000
Oct 07, 2013 $0.400 $0.400 $0.330 $0.380 100 000
Oct 04, 2013 $0.370 $0.400 $0.370 $0.400 20 000
Oct 03, 2013 $0.360 $0.400 $0.360 $0.390 25 000
Oct 02, 2013 $0.390 $0.390 $0.350 $0.360 40 000
Oct 01, 2013 $0.400 $0.430 $0.390 $0.420 40 000
Sep 30, 2013 $0.390 $0.450 $0.370 $0.450 35 000
Sep 27, 2013 $0.460 $0.460 $0.360 $0.360 25 000
Sep 26, 2013 $0.360 $0.450 $0.340 $0.450 80 000
Sep 25, 2013 $0.400 $0.400 $0.340 $0.380 35 000
Sep 24, 2013 $0.470 $0.470 $0.350 $0.400 90 000
Sep 23, 2013 $0.400 $0.470 $0.370 $0.390 120 000
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT